Ultrasound-guided percutaneous injection of triamcinolone acetonide for treating capsular contracture in patients with augmented and reconstructed breast

Luca Maria Sconfienza, Carmelina Murolo, Simone Callegari, Massimo Calabrese, Edoardo Savarino, Pierluigi Santi, Francesco Sardanelli

Research output: Contribution to journalArticle

Abstract

Objectives: To evaluate ultrasound (US)-guided treatment of capsular contracture (CC) in patients with reconstructed/augmented breast. Methods: Twenty-five patients with grade IV CC were treated with peri-implant US-guided injection of triamcinolone acetonide. Before/after treatment, maximum capsular thickness (MCT) was measured by ultrasound and pain assessed with visual analogue score (pain-VAS). Patients with pain relief at 1 month were considered early responders (ERs). Another injection was performed in patients without pain relief at 1 month (late responders, LRs). Results: One patient (treated with chemo-radiotherapy) experienced severe pain and local reaction after the second injection, requiring surgery. Twenty-four patients had baseline MCT of 1.8±0.3 mm and pain-VAS of 4.9±0.5, the baseline MCT of 19 ERs (1.7±0.2 mm) being significantly lower than that of 5 LRs (2.1±0.2 mm) (p=0.030). ERs had significantly reduced MCT and pain-VAS at one (1.1±0.3 mm; 1.5±0.5) and 6 months (1.1±0.2 mm; 0.9±0.7, respectively) (p

Original languageEnglish
Pages (from-to)575-581
Number of pages7
JournalEuropean Radiology
Volume21
Issue number3
DOIs
Publication statusPublished - Mar 2011

Keywords

  • Breast
  • Capsular contracture
  • Triamcinolone acetonide
  • Ultrasound guidance

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Ultrasound-guided percutaneous injection of triamcinolone acetonide for treating capsular contracture in patients with augmented and reconstructed breast'. Together they form a unique fingerprint.

  • Cite this